Last edition
News about "Oral Suspension"
Jubilant Generics Receives USFDA Tentative Approval for Pantoprazole Sodium Oral Suspension
FDA’s tentative approval strengthens Jubilant Generics' US product pipeline and positions the company to launch Pantoprazole Sodium Delayed Release Oral Suspension following patent expiry later this year.
Oral Suspension | 30/06/2026 | By News Bureau
Biocon Receives US FDA Approval for Everolimus Tablets for Oral Suspension
Biocon has secured US FDA approval for Everolimus Tablets for Oral Suspension, enhancing its portfolio of vertically integrated drug products and expanding treatment options for patients in key markets.
Oral Suspension | 13/01/2026 | By News Bureau | 165
Lupin Receives Approval from US FDA for Rivaroxaban for Oral Suspension
Lupin’s Rivaroxaban will be manufactured at the company’s Chhatrapati Sambhajinagar facility.
Oral Suspension | 01/10/2025 | By Dineshwori | 329
Lupin Gets Approval from FDA for Abacavir, Dolutegravir and Lamivudine Tablets
Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension, 60 mg/5 mg/30 mg, (RLD Triumeq PD) had an estimated annual sale of USD 1.3 million in the US.
Oral Suspension | 06/12/2024 | By Aishwarya | 726
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy